Immediate Impact
5 from Science/Nature 82 standout
Citing Papers
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Works of Natasha C. Bergmann being referenced
Semaglutide for the treatment of overweight and obesity: A review
2022 Standout
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Natasha C. Bergmann | 713 | 387 | 206 | 345 | 31 | 1.1k | |
| Annette M. Chang | 783 | 379 | 70 | 444 | 29 | 1.3k | |
| Margarita Barrientos‐Pérez | 738 | 204 | 420 | 287 | 23 | 1.2k | |
| MEJ Lean | 606 | 183 | 453 | 209 | 28 | 1.4k | |
| J. Lundgren | 493 | 348 | 303 | 183 | 29 | 1.4k | |
| Robert J. Tanenberg | 939 | 192 | 95 | 460 | 46 | 1.3k | |
| Amy E. Rothberg | 399 | 195 | 144 | 395 | 57 | 1.3k | |
| Gitanjali Srivastava | 326 | 191 | 381 | 214 | 35 | 978 | |
| Richard D. Carr | 477 | 302 | 73 | 378 | 24 | 1.1k | |
| Antonella Napolitano | 320 | 318 | 156 | 162 | 28 | 1.2k | |
| David Jesudason | 551 | 136 | 204 | 134 | 40 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...